Why the Atlas Arteria share price is rocketing 14% today

Multiple ASX share investors take on one another in a tug of war in a high rise building.

Atlas Arteria Ltd (ASX: ALX) shares are surging on Monday after the toll road operator confirmed it has received a takeover proposal.

At the time of writing, the Atlas Arteria share price is up a massive 14.55% to $4.96.

The move comes after an unsolicited, off-market bid was received this morning from infrastructure investor IFM Investors.

Here’s everything you need to know.

Takeover proposal hits the market

According to the release, IFM Investors has made a bid for all Atlas Arteria securities it doesn’t already own.

The offer is priced at $4.75 per share in cash.

There is also a potential increase to $5.10 per share if IFM lifts its stake to 45% by the close of the offer.

IFM already holds close to 35% of Atlas Arteria, making it the company’s largest shareholder.

At $4.75 per share, the offer represents a modest premium to the last closing price of $4.33. The shares are now trading about 2.3% above the offer price.

The proposal values the company at roughly $6.9 billion.

What’s the next steps?

The offer is not a done deal, just yet.

Atlas Arteria noted that the proposal is subject to a range of conditions, including third-party approvals and other customary requirements.

There is also no guarantee those conditions will be satisfied.

The company has established an independent board committee to assess the proposal.

Advisers have been appointed, with UBS and Flagstaff handling financial advice and Mallesons acting as legal adviser.

Management has advised shareholders to take no action while the offer is being reviewed.

Further updates are expected once the committee has completed its assessment.

Share price reaction

Takeover approaches often change how a stock is valued, even when the premium is not that large.

Right now, the $4.75 offer sits below the current share price, which points to expectations of a higher outcome for shareholders.

And now, attention is already shifting to the $5.10 conditional price.

The fact IFM already owns a large stake adds another layer of complexity.

It already owns more than a third of the business, giving it room to increase its holding and shape how this plays out.

That position can also influence how any deal is structured.

Foolish Takeaway

I don’t think this is the final offer.

The share price is already trading above the bid, which tells you the market is expecting something higher.

IFM is already a major holder, so it has the ability to lean in if it wants control.

At these levels, I’d be more inclined to wait and see if a better price comes through rather than rush into anything.

The post Why the Atlas Arteria share price is rocketing 14% today appeared first on The Motley Fool Australia.

Should you invest $1,000 in Atlas Arteria right now?

Before you buy Atlas Arteria shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Atlas Arteria wasn’t one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys…

* Returns as of 20 Feb 2026

.custom-cta-button p {
margin-bottom: 0 !important;
}

More reading

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.